Intelligent Bio Solutions (INBS) EBT Margin (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly EBT Margin of 349.94% in Q1 2025, up 5.77% quarter-over-quarter from 371.37% in Q4 2024, and up 1250.0% on a YoY basis from 25.92% in Q1 2024.
Intelligent Bio Solutions (INBS) EBT Margin (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' EBT Margin history runs 7 years deep, the most recent figure standing at 349.94% for Q1 2025.
- In Q1 2025, EBT Margin rose 1250.0% year-over-year to 349.94%; the TTM figure through Mar 2025 stood at 340.09% (up 2326.0% YoY), while the FY2023 annual figure was 1001.34%, down 46929.0% from the prior year.
- EBT Margin was 349.94% for Q1 2025 at Intelligent Bio Solutions, up from 371.37% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 174.6% in Q2 2022 to a low of 9164.97% in Q1 2021.
- Historically, EBT Margin has averaged 1140.76% across 5 years, with a median of 362.44% in 2024.
- The sharpest annual moves came in 2021 and 2022: EBT Margin slumped 191728 bps in 2021, then soared 846672 bps in 2022.
- A 5-year view of EBT Margin shows it stood at 1948.26% in 2021, then soared by 69 bps to 597.03% in 2022, then jumped by 56 bps to 264.42% in 2023, then sank by 40 bps to 371.37% in 2024, then gained by 6 bps to 349.94% in 2025.
- The last three EBT Margin figures came in at 349.94% (Q1 2025), 371.37% (Q4 2024), and 308.93% (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -349.94% |
| Dec 31, 2024 | -371.37% |
| Sep 30, 2024 | -308.93% |
| Mar 31, 2024 | -362.44% |
| Dec 31, 2023 | -264.42% |
| Sep 30, 2023 | -322.03% |
| Jun 30, 2023 | -609.84% |
| Mar 31, 2023 | -1,389.76% |
| Dec 31, 2022 | -597.03% |
| Sep 30, 2022 | -348.44% |
| Jun 30, 2022 | -174.60% |
| Mar 31, 2022 | -698.25% |
| Dec 31, 2021 | -1,948.26% |
| Jun 30, 2021 | -201.10% |
| Mar 31, 2021 | -9,164.97% |
| Dec 31, 2020 | -703.23% |
| Sep 30, 2020 | -1,942.94% |
| Jun 30, 2020 | -672.43% |
| Mar 31, 2020 | -7,247.68% |
| Dec 31, 2019 | -232,209.65% |